PHARMA
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2017
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2017 |
| Quarter | 4 Qtr |
| Quarterly report for the financial period ended | 31 Dec 2017 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
31 Dec 2017
|
31 Dec 2016
|
31 Dec 2017
|
31 Dec 2016
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
613,196
|
582,816
|
2,323,960
|
2,189,022
|
| 2 | Profit/(loss) before tax |
19,866
|
4,069
|
73,064
|
72,017
|
| 3 | Profit/(loss) for the period |
22,088
|
-900
|
55,087
|
45,859
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
21,700
|
-836
|
53,823
|
45,599
|
| 5 | Basic earnings/(loss) per share (Subunit) |
8.36
|
-0.32
|
20.74
|
17.60
|
| 6 | Proposed/Declared dividend per share (Subunit) |
6.00
|
3.00
|
19.00
|
16.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
2.0300
|
2.0500
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 27 Feb 2018 |
| Category | Financial Results |
| Reference Number | FRA-26022018-00071 |